September 16, 2011

A diabetes drug made by Bristol-Myers Squibb and AstraZeneca significantly reduced Type 2 diabetes patients' blood-sugar levels, compared with placebo, when added to insulin, according to results of a new study.

August 17, 2011

Patients with gout taking a drug made by Savient Pharmaceuticals experienced "significant" improvements, according to results of two late-stage clinical trials published in the Journal of the American Medical Association.

August 10, 2011

Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

June 29, 2011

Adding an investigational drug for Type 2 diabetes to the common generic drug metformin helped control blood sugar in patients who could not control their blood sugar with metformin alone, according to results of a late-stage clinical study.

May 5, 2011

A major depressive disorder treatment made by Pfizer significantly reduced the number and severity of moderate-to-severe hot flashes in postmenopausal women, compared with placebo, according to a new study.

March 17, 2011

Anglo-Swedish drug maker AstraZeneca has enrolled the first patient in a late-stage clinical trial for a drug to treat constipation related to use of opioid painkillers, the company said.

February 4, 2011

A drug used to treat inflammatory diseases improved the conditions of patients with psoriasis that affected the scalp compared with placebo, according to results of a new study.

January 24, 2011

Advanced Vision Research on Monday announced results from a pilot trial published in the journal Cornea that demonstrated a reduction in dry-eye symptoms and an increase in tear volume and tear flow for those patients taking TheraTears Nutrition, an optimized blend of omega-3 oils.

January 21, 2011

A drug for major depressive disorder worked better than placebo, according to results of a late-stage clinical trial announced Thursday.

December 22, 2010

An over-the-counter herbal supplement believed to improve immunity function has minimal impact in relieving the common cold, according to research by the University of Wisconsin-Madison School of Medicine and Public Health released Monday.

November 14, 2010

A drug made by Pfizer may help decrease the risk of cardiovascular death or heart...

November 2, 2010

A study presented last month before the European Respiratory Society Annual Congress determined that the...

September 26, 2010

An investigational drug made by Johnson & Johnson for treating pain showed significant reduction in...

August 30, 2010

A new study conducted by investigators at Harvard Medical School and Massachusetts General Hospital suggested...

August 29, 2010

An investigational relapsing multiple sclerosis drug significantly reduced annualized relapse rate in a late-stage clinical...

June 16, 2010

An investigational treatment made by Merck for insomnia was more effective than placebo in improving...

June 15, 2010

An investigational drug for rheumatoid arthritis significantly reduced symptoms in patients, according to results of...

May 20, 2010

British drug maker Shire presented late-stage clinical study data at a psychiatric meeting Friday indicating...

March 10, 2010

An investigational drug can reduce seizures in adolescents and adults with epilepsy when added on...

February 28, 2010

Future ex-smokers who use a nicotinepatch therapy longer than currently recommended may be less likely...

February 24, 2010

A late-stage clinical trial of a drug by Genentech indicates that combining it with chemotherapy...

February 22, 2010

The Food and Drug Administration has declined to approve the use of a drug made...

February 2, 2010

A pain drug made by Eli Lilly & Co. “significantly” reduced chronic low back pain...

February 1, 2010

Future ex-smokers who utilize a nicotine-patch therapy longer may be less likely to relapse, according...